Margaret von Mehren

Dr. Margaret von Mehren is a leading sarcoma and GIST expert who serves on the NCCN panel for soft tissue sarcomas and GIST, helping define national treatment guidelines. She has participated in major GIST clinical trials evaluating imatinib in both metastatic and adjuvant settings and has contributed significantly to understanding the prognostic significance of KIT and PDGFRA mutation status in GIST.